We Bring Research To You
Beta thalassemia is a genetic blood disorder that reduces the production of hemoglobin, which leads to a lack of oxygen in many parts of the body. These low levels of hemoglobin may cause anemia. More than 5,000 people in the U.S. are living with beta thalassemia, and better medicine and treatment options are needed for Beta Thalassemia.
We believe patients like you are the key to making a difference in Beta Thalassemia research. Joining a research study can help advance the future of Beta Thalassemia research and impact the development of new treatments and cures.
Sanguine's unique model alleviates many of the difficulties associated with clinical trials and we make it easy for patients to contribute to research for medical conditions that matter most to them, regardless of their location or ability to travel. Sign up to learn more and participate today!
Sanguine's Expertise in Accelerating Research
our community
member has participated
by Sanguine
Nationwide Partners
We partner with these like-minded organizations and nonprofits to connect with patients who want to contribute and help accelerate research.